HRMY

Harmony Biosciences Holdings, Inc. Common Stock
Data: 2026-08-21

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Quick Stats
Aug 21, 2026

48.6

AI Score

HOLD

0.45

Volume Ratio

TBA

Next Earnings

16

+ve Days (30d)

13

-ve Days (30d)

HRMY Stock Summary

Last updated Aug 21, 2026

HRMY is currently trading at $38.15, positioned above its 200-day moving average of $33.83, indicating a long-term uptrend. The stock has a 52-week range of $25.52 to $40.87.

Technical Analysis: The 50-day moving average stands at $36.3, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 53.465, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.112, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates HRMY at 48.6/100 with a HOLD recommendation.

HRMY (Harmony Biosciences Holdings, Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 53.465
CMF (20) 0.112
ROC (10) -0.677
ADX (14) 30.715
Indicator Value
MACD (12,26,9) 0.836
AROONOSC (14) 57.143
WILLAMS %R (14) -59.701
MFI (14) 63.267
HRMY Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

HRMY Price vs Max Options Open Interest
HRMY Max Change In Options Open Interest

HRMY Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

HRMY Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

HRMY Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

HRMY Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Harmony Biosciences Holdings, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.

HRMY Moving Averages Analysis

Harmony Biosciences Holdings, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

Harmony Biosciences Holdings, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

HRMY (Harmony Biosciences Holdings, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 38.8
20 37.83
30 36.85
50 36.3
100 33.51
200 33.83

HRMY Fundamental Analysis

P/E (Forward) 10.6383
P/E (Trailing) 12.949
Market Cap ($) 2.2 billion
Earnings/Share ($) 2.94
Net Profit Margin (%) 0.1888
Dividend/Share ($) --
EPS Estimate Current Year ($) 5.2217
EPS Estimate Next Year ($) 6.6864
WallStreet Target Price ($) 46.10
Most Recent Quarter